Radiation plus heat for advanced cervical cancer
Treatments studied
Part of Cancer, Injuries & trauma, Women’s health & pregnancy clinical trials.
This trial studies whether adding controlled heat (“hyperthermia”) to radiation therapy (or radiation with chemotherapy) can improve outcomes in advanced cervical cancer. It focuses on people who can safely receive intensive pelvic radiation and heat treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cervical cancer confirmed by pathology (tissue biopsy)
- Your cancer is stage IIB to IVA, or earlier stage if you cannot have surgery (inoperable) or you choose not to have surgery
- You are an adult (18 or older) and can give informed consent
- Your cancer has not spread to distant organs (no metastasis), except lymph nodes near the aorta may be involved
- You can safely receive radiation and deep pelvic heat based on your overall health and ability to tolerate treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding immunotherapy to chemotherapy, then giving chemotherapy together with radiation, works better for advanced cervical cancer. It aims to improve cancer control and help people live longer, without major safety issues.
This trial tests a feasibility (“can it be done safely?”) approach that delivers radiation in a shorter schedule for some cervical cancer patients. It also uses weekly cisplatin chemotherapy and includes a radiation procedure called brachytherapy to improve treatment effectiveness.
This trial tests whether adding heat therapy (hyperthermia) to a second round of radiation can help treat cancer that has come back in the same area after previous radiation. It may be an option if your tumor is in a part of the body that can be safely heated, like the belly or limbs.
This trial tests a type of advanced radiation called proton therapy that targets a larger area of the pelvis and abdomen for cervical cancer. It may be an option if your cancer has spread to nearby lymph nodes and you haven't had radiation before.
This trial looks at whether adding chemotherapy after standard chemoradiation helps people with locally advanced cervical cancer. You may be eligible if your MRI after treatment still shows leftover tumor areas and your health and blood tests are within required limits.
This trial tests a combination of an immunotherapy drug (AK104) with internal radiation therapy (I-125 brachytherapy) for cervical cancer that has come back or spread. The goal is to see if this combination can control the cancer and improve survival.
Hear when a new Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.